Published online 30 April 2004
Nucleic Acids Research, 2004, Vol. 32, No. 8 2421-2429
© 2004 Oxford University Press
APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase
1 Unité de Rétrovirologie Moléculaire, 2 Service de la Coordination Scientifique, 3 Unité de Chimie Organique, Institut Pasteur, 28 rue du Docteur Roux, 75724 Paris cedex 15, France and 4 MRC, Clinical Sciences Centre, RNA Editing Group, Faculty of Medicine, Imperial College School of Medicine, Du Cane Road, London W12 ONN, UK
*To whom correspondence should be addressed. Tel: +33 1 45 68 88 21; Fax: +33 1 45 68 88 74; Email: simon{at}pasteur.fr
Received March 5, 2004; Revised and Accepted March 30, 2004
In the absence of the viral vif gene, human immunodeficiency virus (HIV) may be restricted by the APOBEC3G gene on chromosome 22. The role of the HIV Vif protein is to exclude host cell APOBEC3G from the budding virion. As APOBEC3G shows sequence homology to cytidine deaminases, it is presumed that in the absence of Vif, cytidine residues in the cDNA are deaminated yielding uracil. It is not known if additional proteins mediate APOBEC3G function or if deamination occurs in concert with reverse transcription. This report describes an in vitro assay showing that Baculovirus derived APOBEC3G alone extensively deaminates cDNA independently of reverse transcriptase. It reproduces the dinucleotide context typical of G
A hypermutants derived from a
vif virus. By using an RNaseH form of reverse transcriptase, it was shown that the cDNA has to be free of its RNA template to allow deamination. APOBEC3G deamination of dC or dCTP was not detected. In short, APOBEC3G is a single-stranded DNA cytidine deaminase capable of restricting retroviral replication.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Arudchandran, R. M. Bernstein, and E. E. Max Single-strand DNA breaks in Ig class switch recombination that depend on UNG but not AID Int. Immunol., September 15, 2008; (2008) dxn097v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Armitage, A. Katzourakis, T. de Oliveira, J. J. Welch, R. Belshaw, K. N. Bishop, B. Kramer, A. J. McMichael, A. Rambaut, and A. K. N. Iversen Conserved Footprints of APOBEC3G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K(HML2) Sequences J. Virol., September 1, 2008; 82(17): 8743 - 8761. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Suspene, M. Renard, M. Henry, D. Guetard, D. Puyraimond-Zemmour, A. Billecocq, M. Bouloy, F. Tangy, J.-P. Vartanian, and S. Wain-Hobson Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs Nucleic Acids Res., July 1, 2008; 36(12): e72 - e72. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Knoepfel, N. C. Salisch, P. M. Huelsmann, P. Rauch, H. Walter, and K. J. Metzner Comparison of G-to-A Mutation Frequencies Induced by APOBEC3 Proteins in H9 Cells and Peripheral Blood Mononuclear Cells in the Context of Impaired Processivities of Drug-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Variants J. Virol., July 1, 2008; 82(13): 6536 - 6545. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Vartanian, D. Guetard, M. Henry, and S. Wain-Hobson Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions Science, April 11, 2008; 320(5873): 230 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, C. Tian, W. Zhang, K. Luo, P. T. N. Sarkis, L. Yu, B. Liu, Y. Yu, and X.-F. Yu 7SL RNA Mediates Virion Packaging of the Antiviral Cytidine Deaminase APOBEC3G J. Virol., December 1, 2007; 81(23): 13112 - 13124. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Niewiadomska, C. Tian, L. Tan, T. Wang, P. T. N. Sarkis, and X.-F. Yu Differential Inhibition of Long Interspersed Element 1 by APOBEC3 Does Not Correlate with High-Molecular-Mass-Complex Formation or P-Body Association J. Virol., September 1, 2007; 81(17): 9577 - 9583. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Luo, T. Wang, B. Liu, C. Tian, Z. Xiao, J. Kappes, and X.-F. Yu Cytidine Deaminases APOBEC3G and APOBEC3F Interact with Human Immunodeficiency Virus Type 1 Integrase and Inhibit Proviral DNA Formation J. Virol., July 1, 2007; 81(13): 7238 - 7248. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Nguyen, S. Gummuluru, and J. Hu Deamination-Independent Inhibition of Hepatitis B Virus Reverse Transcription by APOBEC3G J. Virol., May 1, 2007; 81(9): 4465 - 4472. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Suspene, C. Rusniok, J.-P. Vartanian, and S. Wain-Hobson Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication Nucleic Acids Res., October 18, 2006; 34(17): 4677 - 4684. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Iwatani, H. Takeuchi, K. Strebel, and J. G. Levin Biochemical Activities of Highly Purified, Catalytically Active Human APOBEC3G: Correlation with Antiviral Effect. J. Virol., June 1, 2006; 80(12): 5992 - 6002. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Chiu and W. C. Greene APOBEC3 Cytidine Deaminases: Distinct Antiviral Actions along the Retroviral Life Cycle J. Biol. Chem., March 31, 2006; 281(13): 8309 - 8312. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tian, X. Yu, W. Zhang, T. Wang, R. Xu, and X.-F. Yu Differential Requirement for Conserved Tryptophans in Human Immunodeficiency Virus Type 1 Vif for the Selective Suppression of APOBEC3G and APOBEC3F J. Virol., March 15, 2006; 80(6): 3112 - 3115. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Delebecque, R. Suspene, S. Calattini, N. Casartelli, A. Saib, A. Froment, S. Wain-Hobson, A. Gessain, J.-P. Vartanian, and O. Schwartz Restriction of Foamy Viruses by APOBEC Cytidine Deaminases J. Virol., January 15, 2006; 80(2): 605 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mahieux, R. Suspene, F. Delebecque, M. Henry, O. Schwartz, S. Wain-Hobson, and J.-P. Vartanian Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases J. Gen. Virol., September 1, 2005; 86(9): 2489 - 2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Mikl, I. N. Watt, M. Lu, W. Reik, S. L. Davies, M. S. Neuberger, and C. Rada Mice Deficient in APOBEC2 and APOBEC3 Mol. Cell. Biol., August 15, 2005; 25(16): 7270 - 7277. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Luo, Z. Xiao, E. Ehrlich, Y. Yu, B. Liu, S. Zheng, and X.-F. Yu Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G PNAS, August 9, 2005; 102(32): 11444 - 11449. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu, P. T. N. Sarkis, K. Luo, Y. Yu, and X.-F. Yu Regulation of Apobec3F and Human Immunodeficiency Virus Type 1 Vif by Vif-Cul5-ElonB/C E3 Ubiquitin Ligase J. Virol., August 1, 2005; 79(15): 9579 - 9587. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Suspene, D. Guetard, M. Henry, P. Sommer, S. Wain-Hobson, and J.-P. Vartanian Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo PNAS, June 7, 2005; 102(23): 8321 - 8326. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Suspene, M. Henry, S. Guillot, S. Wain-Hobson, and J.-P. Vartanian Recovery of APOBEC3-edited human immunodeficiency virus G->A hypermutants by differential DNA denaturation PCR J. Gen. Virol., January 1, 2005; 86(1): 125 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yu, D. Chen, R. Konig, R. Mariani, D. Unutmaz, and N. R. Landau APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication J. Biol. Chem., December 17, 2004; 279(51): 53379 - 53386. [Abstract] [Full Text] [PDF] |
||||







